Teva CEO says not too late to launch Humira biosimilar in 20

By Steven Scheer JERUSALEM (Reuters) -Teva Pharmaceutical Industries will still pursue launching a biosimilar of AbbVie's blockbuster arthritis drug Humira ...

Related Keywords

New York , United States , Jerusalem , Israel General , Israel , Americans , Caroline Humer , Novarti Sandoz , Richard Francis , Steven Scheer , Patrick Wingrove , Unitedhealth Group Optum , Teva Pharmaceutical Industries , Johnson , Boehringer Ingelheim , Cigna Group Express Scripts , Reuters , Amgen , Drug Administration , Chief Executive Richard Francis , Express Scripts , Unitedhealth Group , Bill Berkrot ,